Syros Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 27, 2024)
- Amended and Restated Offer Letter, dated September 28, 2023, by and between the Registrant and Conley Chee (Filed With SEC on November 14, 2023)
- Form of Lock-up Agreement (Filed With SEC on July 5, 2022)
- Forms of Tyme Support Agreement (Filed With SEC on July 5, 2022)
- Form of Syros Support Agreement (Filed With SEC on July 5, 2022)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 15, 2022)
- Offer Letter, effective September 27, 2021, between Syros Pharmaceuticals, Inc. and Conley Chee (Filed With SEC on November 5, 2021)
- Offer Letter, effective October 12, 2021, between Syros Pharmaceuticals, Inc. and Jason Haas (Filed With SEC on October 13, 2021)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 4, 2021)
- Letter Agreement dated November 18, 2019 by and between the Registrant and Incyte Corporation (Filed With SEC on March 5, 2020)
- Offer Letter dated April 24, 2013 by and between the Registrant and Eric R. Olson, Ph.D (Filed With SEC on March 5, 2020)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 5, 2020)
- Offer Letter effective March 12, 2018 between Syros Pharmaceuticals, Inc. and Joseph J. Ferra, Jr (Filed With SEC on March 12, 2018)
- Offer Letter dated November 6, 2017 by and between the Registrant and Jeremy Springhorn, Ph.D (Filed With SEC on March 12, 2018)
- - 1 - (Filed With SEC on March 20, 2017)
